Published in Blood Weekly, July 25th, 2002
The patent, entitled "Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)- quinolinone," U.S. Patent No. 6,388,080, was issued by the U.S. Patent and Trademark Office on May 14, 2002.
Cilostazol is a known arterial vasodilator and antiplatelet agent that is used to treat the symptoms associated with intermittent claudication, a potentially debilitating condition that causes leg pain when exercising.
The invention protected by this patent provides processes for preparing a specific polymorphic form...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.